Appraising evidence for intervention effectiveness in early psychosis: conceptual framework and review of evaluation approaches

References

• Harrison G, Hopper K, Craig T . Recovery from psychotic illness: a 15-and 25-year international follow-up study. Br J Psychiatry 2001;178:506–517.
   PubMed Web of Science ®Google Scholar
• Harrison G, Croudace T, Mason P, Glazebrook C, Medley I. Predicting the long-term outcome of schizophrenia. Psychol Med 1996;26:697–705.
   PubMed Web of Science ®Google Scholar
• Wiersma D, Nienhuis FJ, Slooff CJ, Giel R. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull 1998;24:75–85.
   PubMed Web of Science ®Google Scholar
• Robinson D, Woerner MG, Alvir JMJ . Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999;56:241–247.
   PubMed Web of Science ®Google Scholar
• Kane J, Rifkin A, Quitkin F, Nayak D, Ramos-Lorensi J. Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia. Arch Gen Psychiatry 1982;39:70–73.
   PubMed Web of Science ®Google Scholar
• Crow T, Macmillan J, Johnson A, Johnstone EI. A randomized controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 1986;148:120–127.
   PubMed Web of Science ®Google Scholar
• McCreadie R, Wiles D, Grant S. The Scottish first episode schizophrenia study VII. Two-year follow-up. Acta Psychiatr Scand 1989;80:597–602.
   PubMed Web of Science ®Google Scholar
• Gitlin M, Neuchterlein K, Subotnik KL . Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. Am J Psychiatry 2001:1835–1842.
   PubMed Web of Science ®Google Scholar
• Lieberman J, Jody D, Geisler S . Time-course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 1993;50:369–376.
   PubMed Web of Science ®Google Scholar
• Power P, Elkins K, Adlard S, Curry C, McGorry P, Harrigan S. Analysis of the initial treatment phase in first-episode psychosis. Br J Psychiatry 1998;172:71–76.
   Web of Science ®Google Scholar
• Huq ZU. A trial of low doses of risperidone in the treatment of patients with first-episode schizophrenia, schizophreniform disorder, or schizoaffective disorder. J Clin Psychopharmacol 2004;24:220–224.
   PubMed Web of Science ®Google Scholar
• Emsley R, Rabinowitz J, Medori R. Time course for antipsychotic treatment response in first-episode schizophrenia. Am J Psychiatry 2006;163:743–745.
   PubMed Web of Science ®Google Scholar
• Malla A, Norman R, Schmitz N . Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychol Med 2006;36:649–658.
   PubMed Web of Science ®Google Scholar
• Lieberman J, Koreen A, Chakos M . Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia. J Clin Psychiatry 1996; 57(Suppl 9):5–9.
   PubMed Web of Science ®Google Scholar
• Merlo MCG, Hofer H, Gekle W . Risperidone, 2 mg/day vs. 4 mg/day, in first-episode, acutely psychotic patients: treatment efficacy and effects on fine motor functioning. J Clin Psychiatry 2002;63:885–891.
   PubMed Web of Science ®Google Scholar
• Oosthuizen P, Emsley R, Turner HJ, Keyter N. A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis. Int J Neuropsychopharmacol 2004;7:125–131.
   PubMed Web of Science ®Google Scholar
• Kahn RS, Fleischhacker WW, Boter H . Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 2008; 371(9618):1085–1097.
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Stroup TS, McEvoy JP . Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209–1223.
   PubMed Web of Science ®Google Scholar
• Kavanagh DJ, Young R, White A . A brief motivational intervention for substance misuse in recent-onset psychosis. Drug and Alcohol Review 2004;23:151–155.
   PubMed Web of Science ®Google Scholar
• Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch Gen Psychiatry 2006;63:426–432.
   PubMed Web of Science ®Google Scholar
• Brunette MF, Mueser KT, Drake RE. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug Alcohol Rev 2004; 23:471–481.
   PubMed Web of Science ®Google Scholar
• Jeffery D, Ley A, McLaren S, Siegfried N. Psychosocial treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 2000; (2): CD001088.
   Google Scholar
• Harrigan SM, McGorry PD, Krstev H. Does treatment delay in first-episode psychosis really matter? Psychol Med 2003; 33:97–110.
   PubMed Web of Science ®Google Scholar
• Drake RJ, Haley CJ, Akhtar S, Lewis SW. Causes and consequences of duration of untreated psychosis in schizophrenia. Br J Psychiatry 2000;177:511–515.
   PubMed Web of Science ®Google Scholar
• Marshall M, Rathbone J. Early intervention for psychosis. Cochrane Database Syst Rev 2006; (4):CD004718.
   PubMedGoogle Scholar
• Atkins D, Eccles M, Flottorp S . Systems for grading the quality of evidence and the strength of reccommendations 1: critical appraisal of existing approaches. The Grade Working Group. BMC Health Serv Res 2004;4:38.
   PubMed Web of Science ®Google Scholar
• Black N. Why we need observational studies to evaluate the effectiveness of health care. Br Med J 1996; 312(7040): 1215–1218.
   PubMed Web of Science ®Google Scholar
• Mays N, Roberts E, Popay J. Synthesising research evidence. In: Fulop N, Allen P, Clarke A, Black N, eds. Studying the organisation and delivery of health services: research methods. London: Routledge, 2001:188–220.
   Google Scholar
• Last JM, ed. A dictionary of epidemiology, 4th edn. New York: Oxford University Press, 2001.
   Google Scholar
• Mathison S. Encyclopedia of evaluation. CA: Sage Publications, 2005.
   Google Scholar
• Everitt BS, Howell DC. Encyclopedia of statistics in behavioral science, vols 1-4. West Sussex: John Wiley & Sons, 2005.
   Google Scholar
• Bates S, Clapton J, Coren E. Systematic maps to support the evidence base in social care. Evidence Policy 2007;3:539–551.
   Google Scholar
• Kleijnen J, Gotzche P, Kunz RA, Ozman AD, Chalmers I. So what's so special about randomisation? In: Maynard A, Chalmers I, eds. Non-random reflections on health services research. London, UK: BMJ Publishing, 1997:93–106.
   Google Scholar
• McCulloch CE, Searle SR, Neuhaus JM. Generalized linear and mixed models, 2nd edn.Hoboken, NJ: John Wiley & Sons, 2008.
   Google Scholar
• Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer Science+Business Media, 2000.
   Google Scholar
• Wells KB. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry 1999;156:5–10.
   PubMed Web of Science ®Google Scholar
• Kraemer HC, Gibbons RD. Why does the randomized clinical trial methodology so often mislead clinical decision making? Focus on moderators and mediators of treatment. Psychiatr Ann 2009;39:736–745.
   Web of Science ®Google Scholar
• Macias C, Jones DR, Hargreaves WA . When programs benefit some people more than others: tests of differential service effectiveness. Adm Policy Ment Health Ment Health Serv Res 2008;35:283–294.
   PubMed Web of Science ®Google Scholar
• Pajonk FG. Clinical trial design in schizophrenia: implications for clinical decisions. Curr Opin Psychiatry 2005;18:692–699.
   PubMed Web of Science ®Google Scholar
• Rothwell PM. Treating Individuals 1: external validity of randomised controlled trials: ‘To whom do the results of this trial apply?’ Lancet 2005; 365(9453):82–93.
   PubMed Web of Science ®Google Scholar
• Riedel M, Strassnig M, Muller N, Zwack P, Moller HJ. How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials? Eur Arch Psychiatry Clin Neurosci 2005; 255:143–148.
   PubMed Web of Science ®Google Scholar
• Hofer A, Hummer M, Huber R, Kurtz M, Walch T, Fleischhacker WW. Selection bias in clinical trials with antipsychotics. J Clin Psychopharmacol 2000;20:699–702.
   PubMed Web of Science ®Google Scholar
• Leucht S. Translating research into clinical practice: critical interpretation of clinical trials in schizophrenia. Int Clin Psychopharmacol 2006; 21:S1–S10.
   PubMed Web of Science ®Google Scholar
• Wahlbeck K, Tuunainen A, Ahokas A, Leucht S. Dropout rates in randomised antipsychotic drug trials. Psychopharmacology (Berl) 2001;155:230–233.
   PubMed Web of Science ®Google Scholar
• Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry 2006;163:185–194.
   PubMed Web of Science ®Google Scholar
• Safer DJ. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials. J Nerv Ment Dis 2002;190:583–592.
   PubMed Web of Science ®Google Scholar
• Davis JM, Chen N, Glick ID. Issues that may determine the outcome of antipsychotic trials: industry sponsorship and extrapyramidal side effect. Neuropsychopharmacology 2008;33:971–975.
   PubMed Web of Science ®Google Scholar
• Oakley A, Strange V, Bonell C, Allen E, Stephenson J. Health services research: process evaluation in randomised controlled trials of complex interventions. Br Med J 2006; 332(7538): 413–416.
   PubMed Web of Science ®Google Scholar
• Hawe P, Shiell A, Riley T. Complex interventions: how ‘out of control’ can a randomised controlled trial be? Br Med J 2004; 328(7455):1561–1563.
   PubMed Web of Science ®Google Scholar
• Perera R, Heneghan C, Yudkin P. Graphical methods for depicting randomised trials of complex interventions. BMJ 2007;334:127–129.
   PubMed Web of Science ®Google Scholar
• Campbell M, Fitzpatrick R, Haines A . Framework for design and evaluation of complex interventions to improve health. Br Med J 2000; 321(7262):694–696.
   PubMed Web of Science ®Google Scholar
• Medical Research Council. A framework for development and evaluation of RCTs for complex interventions to improve health. London, UK: MRC, 2000.
   Google Scholar
• van Meijel B, Gamel C, Swieten-Duijfjes B, Grypdonck MHF. The development of evidence-based nursing interventions: methodological considerations. J Adv Nurs 2004;48:84–92.
   PubMed Web of Science ®Google Scholar
• Bradley F, Wiles R, Kinmonth AL, Mant D, Gantley M. Development and evaluation of complex interventions in health services research: case study of the Southampton heart integrated care project (SHIP). Br Med J1999; 318(7185):711–715.
   PubMed Web of Science ®Google Scholar
• Donner A, Klar N. Design and analysis of cluster randomization trials in health research. London: Arnold, 2000.
   Google Scholar
• Medical Research Council. Cluster randomised trials: methodological and ethical considerations. London, UK: MRC, 2002.
   Google Scholar
• Campbell M, Grimshaw J. Cluster randomised trials: time for improvement. Br Med J 1998;317:1171–1172.
   PubMed Web of Science ®Google Scholar
• Puffer S, Torgerson DJ, Watson J. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. Br Med J 2003; 327(7418):785–787.
   PubMed Web of Science ®Google Scholar
• Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003;290:1624–1632.
   PubMed Web of Science ®Google Scholar
• Wolff N. Randomised trials of socially complex interventions: promise or peril? J Health Serv Response Policy 2001; 6:123–126.
   PubMedGoogle Scholar
• Wolff N. Using randomized controlled trials to evaluate socially complex services: problems, challenges and recommendations. J Ment Health Policy Econ 2000;3:97–109.
   PubMedGoogle Scholar
• Sackett D, Haynes R, Guyatt G, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. Boston, MA: Little, Brown, 1991.
   Google Scholar
• Diggle PJ, Heagerty P, Liang K-Y, Zeger SL. Analysis of longitudinal data, 2nd edn. Oxford: Oxford University Press, 2002.
   Google Scholar
• Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experimental designs for generalized causal inference. Boston, MA: Houghton Mifflin, 2002.
   Google Scholar
• Gibbons RD, Brown CH, Hur K . Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007;164:1356–1363.
   PubMed Web of Science ®Google Scholar
• Donabedian A. The quality of care: how can it be assessed. JAMA 1988;260:1743–1748.
   PubMed Web of Science ®Google Scholar
• Chisholm D, Flisher AJ, Lund C . Scale up services for mental disorders: a call for action. Lancet 2007; 370(9594): 1241–1252.
   PubMed Web of Science ®Google Scholar
• Whiteford H. Can research influence mental health policy? Aust N Z J Psychiatry 2001; 35:428–134.
   PubMed Web of Science ®Google Scholar
• Vladeck BC, Kramer PS. Case mix measures: DRGs and alternatives. Annu Rev Public Health 1988;9:333–359.
   PubMed Web of Science ®Google Scholar
• Jones J, Amaddeo F, Barbui C, Tansella M. Predicting costs of mental health care: a critical literature review. Psychol Med 2007;37:467–477.
   PubMed Web of Science ®Google Scholar
• Eagar K, Gaines P, Burgess P. Developing a New Zealand casemix classification for mental health services. World Psychiatry 2004;3:176–181.
   Google Scholar
• Knapp M, Beecham J, Fenyo A, Hallam A. Community mental health care for former hospital inpatients: predicting costs from needs and diagnoses. Br J Psychiatry 1995;166:10–18.
   Web of Science ®Google Scholar
• Taiminen T, Ranta K, Karlsson H . Comparison of clinical and best-estimate research DSM-IV diagnoses in a Finnish sample of first-admission psychosis and severe affective disorder. Nord J Psychiatry 2001;55:107–111.
   PubMed Web of Science ®Google Scholar
• Elhai JD, Calhoun PS, Ford JD. Statistical procedures for analyzing mental health services data. Psychiatry Res 2008;160:129–136.
   PubMed Web of Science ®Google Scholar
• Andrews G, Peters L, Teesson M. The measurement of consumer outcome in mental health: a report to the National Mental Health Information Strategy Committee. Sydney: Clinical Research Unit for Anxiety Disorders, 1994.
   Google Scholar
• Wing JK, Beevor AS, Curtis RH, Park SBG, Hadden S, Burns A. Health of the Nation Outcome Scales (HoNOS): research and development. Br J Psychiatry 1998;172:11–18.
   PubMed Web of Science ®Google Scholar
• Happell B. The value of routine outcome measurement for consumers of mental health services: master or servant? Int J Soc Psychiatry 2008; 54:317–327.
   PubMed Web of Science ®Google Scholar
• Kisely S, Preston N, Rooney M. Pathways and outcomes of psychiatric care: does it depend on who you are, or what you've got? Aust N Z J Psychiatry 2000; 34:1009–1014.
   PubMed Web of Science ®Google Scholar
• Fossey EM, Harvey CA. A conceptual review of functioning: implications for the development of consumer outcome measures. Aust N Z J Psychiatry 2001;35:91–98.
   PubMed Web of Science ®Google Scholar
• Gilbody SM, House AO, Sheldon TA. Outcomes research in mental health: systematic review. Br J Psychiatry 2002;181:8–16.
   PubMed Web of Science ®Google Scholar
• Bilsker D, Goldner EM. Routine outcome measurement by mental health-care providers: is it worth doing? Lancet 2002; 360(9346): 1689–1690.
   PubMed Web of Science ®Google Scholar
• Slade M, Thornicroft G, Glover G. The feasibility of routine outcome measures in mental health. Soc Psychiatry Psychiatr Epidemiol 1999;34:243–249.
   PubMed Web of Science ®Google Scholar
• Dickey B, Wagenaar H. Evaluating mental health care reform: including the clinician, client, and family perspective. J Ment Health Adm 1994;21:313–319.
   PubMedGoogle Scholar
• Lloyd-Evans B, Johnson S, Slade M. Assessing the content of mental health services: a review of measures. Soc Psychiatry Psychiatr Epidemiol 2007;42:673–682.
   PubMed Web of Science ®Google Scholar
• Salize HJ, Kustner BM, Torres-Gonzalez F, Reinhard I, Estevez JFJ, Rossler W. Needs for care and effectiveness of mental health care provision for schizophrenic patients in two European regions: a comparison between Granada (Spain) and Mannheim (Germany). Acta Psychiatr Scand 1999;100:328–334.
   PubMed Web of Science ®Google Scholar
• De Jong A, Giel R, Tentlom G. International classification of mental health care: a tool for classifying service providing mental health care Part 1. Groningen: Department of Social Psychiatry, University of Groningen and World Health Organisation Regional office for Europe, 1991.
   Google Scholar
• Johnson S, Kuhlmann R, EPCAT Group. The European Service Mapping Schedule (ESMS): development of an instrument for the description and classification of mental health services. Acta Psychiatr Scand 2000;102:14–23.
   Web of Science ®Google Scholar
• Becker T, Hulsmann S, Knudsen HC . Provision of services for people with schizophrenia in five European regions. Soc Psychiatry Psychiatr Epidemiol 2002;37:465–474.
   PubMed Web of Science ®Google Scholar
• Palmer RH, Reilly MC. Individual and institutional variables which may serve as indicators of quality of medical care. Med Care 1979;17:693–717.
   PubMed Web of Science ®Google Scholar
• Preston NJ, Stirling ML, Perera K . A statewide evaluation system for early psychosis. Aust N Z J Psychiatry 2003;37:421–428.
   PubMed Web of Science ®Google Scholar
• Doran T, Fullwood C, Kontopantelis E, Reeves D. Effect of financial incentives on inequalities in the delivery of primary clinical care in England: analysis of clinical activity indicators for the quality and outcomes framework. Lancet 2008; 372(9640): 728–736.
   PubMed Web of Science ®Google Scholar
• Starfield B. Quality and outcomes framework: patient-centred? Lancet 2008; 372(9640):692–694.
   PubMed Web of Science ®Google Scholar
• Minas H, Cohen A. Why focus on mental health systems? Int J Ment Health Syst 2007; 1:1.
   PubMedGoogle Scholar
• Rossi PH, Lipsey MW, Freeman HE. Evaluation: a systematic approach, 7th edn. CA: Thousand Oaks, 2004.
   Google Scholar
• Smith MF. Evaluability assessment: a practical approach. Boston: Kluwer Academic, 1989.
   Google Scholar
• Sadish WR, Cook TD, Leviton LC. Foundations of program evaluation: theories of practice. Newbury Park, CA: Sage Publications, 1991.
   Google Scholar
• Nutbeam D, Bauman A. Evaluation in a nutshell. Sydney: McGraw-Hill Australia, 2006.
   Google Scholar
• Mowbray CT, Holter MC, Teague GB, Bybee D. Fidelity criteria: development, measurement, and validation. Am J Eval 2003;24:315–340.
   Web of Science ®Google Scholar
• Drummond MF, Sculpher MJ, Torrance GW, O'Brien B, J., Stoddart GL. Methods for the economic evaluation of health care programmes, 3rd edn. New York: Oxford University Press, 2005.
   Google Scholar
• National Health Medical Research Council. How to compare the costs and benefits: evaluation of the economic evidence. Canberra: 2001.
   Google Scholar
• Roberts E, Cumming J, Nelson K. A review of economic evaluations of community mental health care. Med Care Res Rev 2005;62:503–543.
   PubMed Web of Science ®Google Scholar
• Evers S, Salvador-Carulla L, Halsteinli V, McDaid D, Group TM. Implementing mental health economic evaluation evidence: building a bridge between theory and practice. J Ment Health 2007;16:223–241.
   Google Scholar
• Donaldson C, Mugford M, Vale L. Evidence-based health economics: from effectiveness to efficiency in systematic review. London: BMJ Books, 2002.
   Google Scholar
• Hermann RC. Improving mental healthcare: a guide to measurement-based quality improvement. Washington, DC: American Psychiatric Publications, 2005.
   Google Scholar
• Buttery Y, Walshe K, Coles J, Bennett J. Evaluating medical audit: the development of audit findings of national survey of healthcare provider units in England. London: Clinical Accountability, Service Planning and Evaluation (CASPE) Research, 1994.
   Google Scholar
• Buxton MJ. Achievements of audit in the NHS. Qual Health Care 1994; l(Suppl):531–534.
   Google Scholar
• Nelson EAS. Standardized program for medical audit is needed. Br Med J 1994; 309(6955):672–673.
   Google Scholar
• O'Neil D, Hicks D, Smalley S. Central dimensions of clinical practice evaluation: efficiency, appropriateness and effectiveness. J Eval Clin Pract 1996;2:13–27.
   PubMedGoogle Scholar
• Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2006; (2):CD000259.
   PubMed Web of Science ®Google Scholar
• Miles A, Lugon M. Effective clinical practice. Oxford: Blackwell Science, 1996.
   Google Scholar
• Bhopal R, Thompson R. Medical audit and medical research. Qual Health Care 1992;2:274–275.
   Google Scholar
• Walshe K, Coles J. Evaluation audit: a review of initiatives. London: Clinical Accountability, Service Planning and Evaluation (CASPE) Research, 1994.
   Google Scholar
• Shaw CD, Costain DW. Guidelines for medical audit: seven principles. Br Med J 1989; 299(6697):498–199.
   PubMed Web of Science ®Google Scholar
• Jenkins R. Towards a system of outcome indicators for mental health care. Br J Psychiatry 1990;157:500–514.
   PubMed Web of Science ®Google Scholar
• Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care 2003;15:523–530.
   PubMed Web of Science ®Google Scholar
• Mainz J. Developing evidence-based clinical indicators: a state of the art methods primer. Int J Qual Health Care 2003;15:15–111.
   PubMed Web of Science ®Google Scholar
• Brugha TS, Lindsay F. Quality of mental health service care: the forgotten pathway from process to outcome. Soc Psychiatry Psychiatr Epidemiol 1996;31:89–98.
   PubMed Web of Science ®Google Scholar
• Ganju V. Implementation of evidence-based practices in state mental health systems: implications for research and effectiveness studies. Schizophr Bull 2003;29:125–131.
   PubMed Web of Science ®Google Scholar
• Goldman H, Thelander S, Westrin C-G. Organising mental health services: an evidence-based approach. J Ment Health Policy Econ 2000;3:69–75.
   PubMedGoogle Scholar
• Polcin DL. How health services research can help clinical trials become more community relevant. Int J Drug Policy 2006;17:230–237.
   Web of Science ®Google Scholar
• Beinecke RH, Shepard DS, Hurley CL. Implementing evidence-based mental health practices and performance measures in Massachusetts. Adm Policy Ment Health Ment Health Serv Res 2006;33:623–628.
   PubMed Web of Science ®Google Scholar
• Rubin HR, Pronovost P, Diette GB. The advantages and disadvantages of process-based measures of health care quality. Int J Qual Health Care 2001;13:469–474.
   PubMed Web of Science ®Google Scholar
• Rubin HR, Pronovost P, Diette GB. From a process of care to a measure: the development and testing of a quality indicator. Int J Qual Health Care 2001;13:489–496.
   PubMed Web of Science ®Google Scholar
• Tansella M, Thornicroft G. A conceptual framework for mental health services: the matrix model. Psychol Med 1998;28:503–508.
   PubMed Web of Science ®Google Scholar
• Meehan TJ, Stedman TJ, Neuendorf KE, Francisco ID, Neilson MG. Benchmarking Australia's mental health services: is it possible and useful? Aust Health Rev 2007; 31:623–627.
   PubMed Web of Science ®Google Scholar
• Juran JM, Gryna FM. Quality control handbook, 4th edn. New York: McGraw Hill, 1988.
   Google Scholar
• Deming WE. Out of the crisis. Cambridge: Cambridge University Press, 1982.
   Google Scholar
• Berwick DM. Developing and testing changes in delivery of care. Ann Intern Med 1998;128:651–656.
   PubMed Web of Science ®Google Scholar
• Hart E, Bond M. Action research for health and social care: a guide to practice. Buckingham, UK: Open University Press, 1995.
   Google Scholar
• Stringer E, Genat W. Action research in health. New Jersey: Pearson Education, 2004.
   Google Scholar
• Reason J. Managing the risks of organizational accidents. Ashgate: Aldershot, 1997.
   Google Scholar
• Kaplan R, Norton D. The balanced scorecard: translating strategy into action. Cambridge, MA: Harvard Business School Press, 1996.
   Google Scholar
• Camp RC. Benchmarking: the search for industry best practices that lead to superior performance. Portland, OR: Productivity Press, 2006.
   Google Scholar
• Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't - it's about integrating individual clinical expertise and the best external evidence. Br Med J 1996; 312(7023):71–72.
   PubMed Web of Science ®Google Scholar
• Lohr KN, Eleazer K, Mauskopf J. Health policy issues and applications for evidence-based medicine and clinical practice guidelines. Health Policy 1998;46:1–19.
   PubMed Web of Science ®Google Scholar
• Sale D. Understanding clinical governance and quality assurance. Hampshire: Palgrave McMillan, 2005.
   Google Scholar
• Brennan TA, Leape IJ, Laird NM . Incident of adverse events and negligent care in hospitalised patients. Results of Harvard Medical Practice Study 1. N Engl J Med 1991;324:370–376.
   PubMed Web of Science ®Google Scholar
• Wilson RM, Runciuman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD. The Quality in Australian Health Care Study. Med J Aust 1995; 163:458–171.
   PubMed Web of Science ®Google Scholar
• Zarin DA, Pincus HA, West JC, McIntyre JS. Practice-based research in psychiatry. Am J Psychiatry 1997;154:1199–1208.
   PubMed Web of Science ®Google Scholar
• Pincus HA, Zarin DA, Tanielian TL . Psychiatric patients and treatments in 1997: findings from the American Psychiatric Practice Research Network. Arch Gen Psychiatry 1999; 56:441–449.
   PubMed Web of Science ®Google Scholar
• Norquist GS. Practice research networks: promises and pitfalls. Clin Psychol Sci Pract 2001;8:173–175.
   Web of Science ®Google Scholar
• Borkovec TD, Echemendia RJ, Ragusea SA, Ruiz M. The Pennsylvania Practice Research Network and future possibilities for clinically meaningful and scientifically rigorous psychotherapy effectiveness research. Clin Psychol Sci Pract 2001;8:155–167.
   Web of Science ®Google Scholar
• National Health and Medical Research Council. How to use the evidence: assessment and application of scientific evidence. Canberra: Commonwealth of Australia, 2000.
   Google Scholar
• National Health and Medical Research Council. How to review the evidence: systematic identification and review of the scientific literature. Canberra: Commonwealth of Australia, 2000.
   Google Scholar
• National Health and Medical Research Council. How to put the evidence into practice: implementation and dissemination strategies. Canberra: Commonwealth of Australia, 2000.
   Google Scholar
• Andrews G. Randomised controlled trials in psychiatry: important but poorly accepted. Br Med J 1999; 319(7209):562–564.
   PubMed Web of Science ®Google Scholar
• National Institute of Clinical Studies. Assessing the implementability of guidelines. Melbourne: National Institute of Clinical Studies, 2006.
   Google Scholar
• Cluzeau F, Burgers J, Brouwers M . Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003;12:18–23.
   PubMedGoogle Scholar
• Yealy DM, Auble TE, Stone RA . Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med 2005; 143(12):881–894.
   PubMed Web of Science ®Google Scholar
• Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. Br Med J 1998; 316(7125): 133–137.
   PubMed Web of Science ®Google Scholar
• Evans-Lacko SE, Jarrett M, McCrone P, Thornicroft G. Clinical pathways in psychiatry. Br J Psychiatry 2008;193:4–5.
   PubMed Web of Science ®Google Scholar
• Yellowlees PM, Emmerson B, Denton M, Wentworth S, Dart J. Clinical pathways in mental health. Brisbane: Royal Australian and New Zealand College of Psychiatrists, 2002.
   Google Scholar
• Coffey RJ, Richards JS, Remmert CS, LeRoy SS, Schoville RR, Baldwin PJ. An introduction to critical paths (hospital and quality management). Qual Manag Health Care 2005;14:46.
   PubMedGoogle Scholar
• Huby G, Rees G. The effectiveness of quality improvement tools: joint working in integrated community teams. Int J Qual Health Care 2005;17:53–58.
   PubMed Web of Science ®Google Scholar
• Emmerson B, Frost A, Fawcett L, Ballantyne E, Ward W, Catts S. Do clinical pathways really improve performance in mental health settings? Australas Psychiatry 2006; 14:395–398.
   PubMedGoogle Scholar
• Jones B, Kenward MG. Design and analysis of cross-over trials, 2nd edn. Boca Raton: Chapman & Hall/CRC, 2003.
   Google Scholar
• Eccles M, Grimshaw J, Campbell M, Ramsay C. Research designs for studies evaluating the effectiveness of change and improvement strategies. Qual Saf Health Care 2003;12:47–52.
   PubMed Web of Science ®Google Scholar
• Speer D. Mental health outcome evaluation. San Diego, CA: Academic Press, 1998.
   Google Scholar
• Trochim WMK, Donnelly JP. The research methods knowledge base, 3rd edn. Mason, OH: Atomic Dog, 2008.
   Google Scholar
• Yin RK. Case study research: design and methods, 3rd edn. Thousand Oaks, CA: Sage Publications, 2003.
   Google Scholar
• Speer DC. Clinically significant change: Jacobson and Truax (1991) revisited. J Consult Clin Psychol 1992; 60:402–408.
   PubMed Web of Science ®Google Scholar
• Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12–19.
   PubMed Web of Science ®Google Scholar
• Farmer A. The demise of the published case report: is resuscitation necessary? Br J Psychiatry 1999; 174:93–94.
   PubMed Web of Science ®Google Scholar
• Dalziel K, Round A, Stein K, Garside R, Castelnuovo E, Payne L. Do the findings of case series studies vary significantly according to methodological characteristics? Health Technol Assess 2005; 9(2): 1.
   Web of Science ®Google Scholar
• Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med 2006;25:1768–1797.
   PubMed Web of Science ®Google Scholar
• Angst J, Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry 2000; 48:445–457.
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Faraone SV, Spencer T, Wilens TE, Wozniak J. Pediatric mania: a developmental subtype of bipolar disorder? Biol Psychiatry 2000; 48:458–466.
   PubMed Web of Science ®Google Scholar
• Walter S, Rey JM, Dekker F. The humble case report. Aust N Z J Psychiatry 2001;35:240–245.
   PubMed Web of Science ®Google Scholar
• Dattilio FM. Does the case study have a future in the psychiatric literature? Int J Psychiatry Clin Pract 2006; 10:195–203.
   PubMed Web of Science ®Google Scholar
• Stiles WB. When is a case study scientific research? Psychother Bull 2003; 38:6–11.
   Google Scholar
• Davies J, Howells K, Jones L. Evaluating innovative treatments in forensic mental health: a role for single case methodology? J Forensic Psychiatry Psychol 2007; 18:353–367.
   Web of Science ®Google Scholar
• Adams CE, Fenton MKP, Quraishi S, David AS. Systematic meta-review of depot antipsychotic drugs for people with schizophrenia. Br J Psychiatry 2001;179:290–299.
   PubMed Web of Science ®Google Scholar
• Keech A, Gebski V, Pike R. Interpreting and reporting clinical trials: a guide to the CONSORT statement and the principles of randomised controlled trials. Pyrmont: Australasian Medical Publishing, 2007.
   Google Scholar
• Altman DG, Schulz KF, Moher D . The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663–694.
   PubMed Web of Science ®Google Scholar
• Singer JDA, Willett JB. Applied longitudinal data analysis: modeling change and event occurence. Oxford: Oxford University Press, 2003.
   Google Scholar
• Popay J, Roberts J, Sowden H, Petticrew M, Arai M, Rodgers L. Guidance on the conduct of narrative synthesis in systematic reviews: version 2. Lancaster, UK: Lancaster University, 2005.
   Google Scholar
• Arai L, Britten N, Popay J . Testing methodological developments in the conduct of narrative synthesis: a demonstration review of research on the implementation of smoke alarm interventions. Evidence Policy 2007;3:361–383.
   Google Scholar
• Guyatt G. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA 1992; 268 (17):2420–2425.
   PubMed Web of Science ®Google Scholar
• Everitt BS, Wessely S. Clinical trials in psychiatry. Oxford: Oxford University Press, 2004.
   Google Scholar
• Friedman LM, Furberg CD, DeMets D. Fundamentals of clinical trials, 3rd. New York: Springer-Verlag, 1998.
   Google Scholar
• Haynes BR, Sackett DL, Guyatt GH, Tugwell P. Clinical epidemiology: how to do clinical practice research, 3rd edn. Philadelphia: Lippincott Williams & Wilkins, 2005.
   Google Scholar
• Grobbee D, Hoes AW. Principles and methods of clinical epidemiology. Sudbury, MA: Jones and Bartlett Publishers, 2008.
   Google Scholar
• Levin BL, Petrila J, Hennessy KD. Mental health services: a public health perspective, 2nd. New York: Oxford University Press, 2004.
   Google Scholar
• Thornicroft G, Tansella M. The mental health matrix: a manual to improve services. Cambridge: Cambridge University Press, 1999.
   Google Scholar
• Orwin RG, Goldman HH. Evaluating alcohol, drug abuse, and mental health services. Levin BL, Petrila J, Hennessy KD. managing mental health systems, 2nd. Oxford: Oxford University Press; 2004:419–466.
   Google Scholar
• Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res 2005;8:19–32.
   Google Scholar
• Emsley RA. Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Schizophr Bull 1999;25:721–729.
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Tollefson G, Tohen M . Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanza-pine versus haloperidol. Am J Psychiatry 2003;160:1396–1404.
   PubMed Web of Science ®Google Scholar
• Green AI, Lieberman JA, Hamer RM . Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophr Res 2006;86:234–243.
   PubMed Web of Science ®Google Scholar
• Schooler N, Rabinowitz J, Davidson M . Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry 2005;162:947–953.
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Phillips M, Gu HB . Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology 2003;28:995–1003.
   PubMed Web of Science ®Google Scholar
• McGorry PD, Yung AR, Phillips LJ . Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002;59:921–928.
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Zipursky RB, Perkins D . Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006;163:790–799.
   PubMed Web of Science ®Google Scholar
• Catts SV, Frost ADJ, Gifford S, Scott J. Real-world use of quetiapine in early psychosis: an acute inpatient and community follow-up effectiveness study. Int J Psychiatry Clin Pract 2008;12:65–73.
   PubMed Web of Science ®Google Scholar
• Kumra S, Oberstar JV, Sikich L . Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia. Schizophr Bull 2008;34:60–71.
   PubMed Web of Science ®Google Scholar
• Strassnig M, Miewald J, Keshavan M, Ganguli R. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis. Schizophr Res 2007;93:90–98.
   PubMed Web of Science ®Google Scholar
• Leucht S, Barnes TRE, Kissling W, Engel RR, Correll C, Kane JM. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry 2003;160:1209–1222.
   PubMed Web of Science ®Google Scholar
• Kumra S, Kranzler H, Gerbino-Rosen G . Clozapine and ‘high-dose’ olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison. Biol Psychiatry 2008;63:524–529.
   PubMed Web of Science ®Google Scholar
• Power P, Iacoponi E, Reynolds N . The Lambeth early onset crisis assessment team study: general practitioner education and access to an early detection team in first-episode psychosis. Br J Psychiatry 2007; 191:S133–S139.
   Web of Science ®Google Scholar
• Tait L, Lester H, Birchwood M, Freemantle N, Wilson S. Design of the BiRmingham Early Detection In untREated psyChosis Trial (REDIRECT): cluster randomised controlled trial of general practitioner education in detection of first episode psychosis [ISRCTN87898421]. BMC Health Serv Res 2005;5:19.
   PubMed Web of Science ®Google Scholar
• Harvey P-O, Lepage M, Malla A. Benefits of enriched intervention compared with standard care for patients with recent-onset Psychosis, a metaanalytic approach. Can J Psychiatry 2007; 52:464–472.
   PubMed Web of Science ®Google Scholar
• Edwards J, McGorry P. Implementing early intervention in psychosis: a guide to establishing early psychosis services. London: Martin Dunitz, 2002.
   Google Scholar
• Grawe RW, Falloon IRH, Widen JH, Skogvoll E. Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study. Acta Psychiatr Scand 2006;114:328–336.
   PubMed Web of Science ®Google Scholar
• Thorup A, Petersen L, Jeppesen P . Integrated treatment ameliorates negative symptoms in first episode psychosis: results from the Danish OPUS trial. Schizophr Res 2005;79:95–105.
   PubMed Web of Science ®Google Scholar
• Bertelsen M, Jeppesen P, Petersen L . Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness. Arch Gen Psychiatry 2008;65:762–771.
   PubMed Web of Science ®Google Scholar
• March JS, Silva SG, Compton S, Shapiro M, Califf R, Krishnan R. The case for practical clinical trials in psychiatry. Am J Psychiatry 2005;162:836–846.
   PubMed Web of Science ®Google Scholar
• Fleischhacker WW, Widschwendter CG. Treatment of schizophrenia patients: comparing new-generation antipsychotics to each other. Curr Opin Psychiatry 2006;19:128–134.
   PubMed Web of Science ®Google Scholar
• Stroup TS, Alves WM, Hamer RM, Lieberman JA. Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations. Nat Rev Drug Discov 2006;5:133–146.
   PubMed Web of Science ®Google Scholar
• Kasper S, Winkler D. Addressing the limitations of the CATIE study. World J Biol Psychiatry 2006;7:126–127.
   PubMed Web of Science ®Google Scholar
• Ragins M. Should the CATIE study be a wake-up call? Psychiatr Serv 2005; 56:1489.
   PubMed Web of Science ®Google Scholar
• Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 2003;60:553–564.
   PubMed Web of Science ®Google Scholar
• Leucht S, Corves C, Arbter D, Engel RR, Li CB, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009; 373(9657):31–41.
   PubMed Web of Science ®Google Scholar
• Nasrallah HA, Meyer JM, Goff DC . Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res 2006;86:15–22.
   PubMed Web of Science ®Google Scholar
• McEvoy JP, Lieberman JA, Perkins DO . Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry 2007;164:1050–1060.
   PubMed Web of Science ®Google Scholar
• Hotopf M, Churchill R, Lewis G. Pragmatic randomised controlled trials in psychiatry. Br J Psychiatry 1999;175:217–223.
   PubMed Web of Science ®Google Scholar
• Hotopf M. The pragmatic randomised control trial. Adv Psychiatr Treat 2002;8:326–333.
   Google Scholar
• Rosenheck RA. Pharmacotherapy of first-episode schizophrenia. Lancet 2008; 371(9618): 1048–1049.
   PubMed Web of Science ®Google Scholar
• D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17 (19):2265–2281.
   PubMed Web of Science ®Google Scholar
• Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127:757–763.
   PubMed Web of Science ®Google Scholar
• Sturmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 2006;59:437–447.
   PubMed Web of Science ®Google Scholar
• McMahon AD. Approaches to combat with confounding by indication in observational studies of intended drug effects. Pharmacoepidemiol Drug Saf 2003; 12:551–558.
   PubMed Web of Science ®Google Scholar
• Foster EM. Propensity score matching: an illustrative analysis of dose response. Med Care 2003;41:1183–1192.
   PubMed Web of Science ®Google Scholar
• Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health 1998;19:17–34.
   PubMed Web of Science ®Google Scholar
• Martens EP, Pestman WR, de Boer A, Belitser SV, Klungel OH. Instrumental variables application and limitations. Epidemiology 2006;17:260–267.
   PubMed Web of Science ®Google Scholar
• Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007;297:278–285.
   PubMed Web of Science ®Google Scholar
• McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? JAMA 1994; 272:859–866.
   PubMed Web of Science ®Google Scholar
• Fortney J, Rost K, Zhang ML, Warren J. The impact of geographic accessibility on the intensity and quality of depression treatment. Med Care 1999;37:884–893.
   PubMed Web of Science ®Google Scholar
• Goldstein H. Multilevel statistical models, 2nd edn. New York: Halstead Press, 1995.
   Google Scholar
• Raudenbush SW, Bryk AS. Hierarchical linear models: applications and data analysis methods. London: Sage Publications, 2002.
   Google Scholar
• Streiner D. The case of the missing data: methods of dealing with dropouts and other research vagaries. Res Methods Psychiatry 2002;47:70–77.
   Google Scholar
• Rosenbaum PR. Observational studies 2nd edn. New York: Springer-Verlag, 2002.
   Google Scholar
• Scharfstein DO, Rotnitzky A, Robins JM. Adjusting for nonignorable drop-out using semiparametric nonresponse models. J Am Stat Assoc 1999; 94 (448): 1096–1120.
   Web of Science ®Google Scholar
• Beunckens C, Molenberghs G, Thijs H, Verbeke G. Incomplete hierarchical data. Stat Methods Med Res 2007; 16:457–492.
   PubMed Web of Science ®Google Scholar
• Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000; 342 (25): 1878–1886.
   PubMed Web of Science ®Google Scholar
• Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342 (25): 1887–1892.
   PubMed Web of Science ®Google Scholar
• Jablensky A, Sartorius N, Ernberg G . Schizophrenia: manifestations, incidence and course in different cultures. Psychol Med 1992; (Suppl 20): 1–97.
   Google Scholar
• Kirkbride JB, Fearon P, Morgan C . Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AESOP study. Arch Gen Psychiatry 2006;63:250–258.
   PubMed Web of Science ®Google Scholar
• Bebbington P, Ramana R. The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol 1995;30:279–292.
   PubMed Web of Science ®Google Scholar
• Peraala J, Suvisaari J, Saarni SI . Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007;64:19–28.
   PubMed Web of Science ®Google Scholar
• Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med 2005; 2:413–433.
   Web of Science ®Google Scholar
• Baldwin P, Browne D, Scully PJ . Epidemiology of first-episode psychosis: illustrating the challenges across diagnostic boundaries through the Cavan-Monaghan study at 8 years. Schizophr Bull 2005;31:624–638.
   PubMed Web of Science ®Google Scholar
• Singh SP, Burns T, Amin S, Jones PB, Harrison G. Acute and transient psychotic disorders: precursors, epidemiology, course and outcome. Br J Psychiatry 2004; 185:452–459.
   PubMed Web of Science ®Google Scholar
• Sajith SG, Chandrasekaran R, Unni KES, Sahai A. Acute polymorphic psychotic disorder: diagnostic stability over 3 years. Acta Psychiatr Scand 2002;105:104–109.
   PubMed Web of Science ®Google Scholar
• Jorgensen P, Bennedsen B, Christensen J, Hyllested A. Acute and transient psychotic disorder: a 1-year follow-up study. Acta Psychiatr Scand 1997;96:150–154.
   PubMed Web of Science ®Google Scholar
• Morgan C, Mallett R, Hutchinson G . Pathways to care and ethnicity. I: sample characteristics and compulsory admission - report from the AESOP study. Br J Psychiatry 2005;186:281–289.
   PubMed Web of Science ®Google Scholar
• Morgan C, Fearon P, Hutchinson G . Duration of untreated psychosis and ethnicity in the AESOP first-onset psychosis study. Psychol Med 2006;36:239–247.
   PubMed Web of Science ®Google Scholar
• Hafner H, Maurer K, Ruhrmann S . Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci 2004;254:117–128.
   PubMed Web of Science ®Google Scholar
• Hafner H, Maurer K, Trendler G, an der Heiden W, Schmidt M, Konnecke R. Schizophrenia and depression: challenging the paradigm of two separate diseases - a controlled study of schizophrenia, depression and healthy controls. Schizophr Res 2005;77:11–24.
   PubMed Web of Science ®Google Scholar
• Friis S, Larsen TK, Melle I . Methodological pitfalls in early detection studies: the NAPE Lecture 2002. Acta Psychiatr Scand 2003;107:3–9.
   PubMed Web of Science ®Google Scholar
• O'Toole BI. Screening for low prevalence disorders. Aust N Z J Psychiatry 2000; 34:S39–S46.
   PubMed Web of Science ®Google Scholar
• Jablensky A. Prevalence and incidence of schizophrenia spectrum disorders: implications for prevention. Aust N Z J Psychiatry 2000; 34:S26–S34.
   PubMed Web of Science ®Google Scholar
• Amminger GP, Harris MG, Conus P . Treated incidence of first-episode psychosis in the catchment area of EPPIC between 1997 and 2000. Acta Psychiatr Scand 2006;114:337–345.
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Perkins D, Belger A . The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry 2001; 50:884–897.
   PubMed Web of Science ®Google Scholar
• Hafner H, Loffler W, Maurer K, Hambrecht M, an der Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand 1999;100:105–118.
   PubMed Web of Science ®Google Scholar
• Job DE, Whalley HC, Johnstone EC, Lawrie SM. Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage 2005;25:1023–1030.
   PubMed Web of Science ®Google Scholar
• Bilder RM, Reiter G, Bates J . Cognitive development in schizophrenia: follow-back from the first episode. J Clin Exp Neuropsychol 2006;28:270–282.
   PubMed Web of Science ®Google Scholar
• McGorry PD, Yung AR, Bechdolf A, Amminger P. Back to the future: predicting and reshaping the course of psychotic disorder. Arch Gen Psychiatry 2008;65:25–27.
   PubMed Web of Science ®Google Scholar
• Catts S. Identifying the young person at risk of psychosis. Med Today 2008;9:961–965.
   Google Scholar
• Phillips CD. What do you do for a living? Toward a more succinct definition of health services research. BMC Health Serv Res 2006;6:117.
   PubMed Web of Science ®Google Scholar
• Scott I, Campbell D. Health services research: what is it and what does it offer? Intern Med J 2002;32:91–99.
   PubMed Web of Science ®Google Scholar
• Scallet LJ, Robinson GK. Opportunities in mental health services research. Health Aff (Millwood) 1993;12:240–250.
   PubMed Web of Science ®Google Scholar
• Wells K, Miranda J, Bruce ML, Alegria M, Wallerstein N. Bridging community intervention and mental health services research. Am J Psychiatry 2004;161:955–963.
   PubMed Web of Science ®Google Scholar
• Burns T, Creed F, Fahy T, Thompson S, Tyrer J, White I for the UK 700 Group. Intensive versus standard case management for severe psychotic illness: a randomised trial. Lancet 1999;354:1128.
   Web of Science ®Google Scholar
• Marshall M, Gray A, Lockwood A, Green R. Case management for people with severe mental disorders. Cochrane Database Syst Rev 1998; (2):CD000050.
   Google Scholar
• Burns T, Creed F, Fahy T . Intensive versus standard case management for severe psychotic illness: a randomised trial. Lancet 1999; 353 (9171):2185–2189.
   PubMed Web of Science ®Google Scholar
• Wykes T, Leese M, Taylor R, Phelan M. Effects of community services on disability and symptoms: PRiSM Psychosis Study 4. Br J Psychiatry 1998;173:385–390.
   PubMed Web of Science ®Google Scholar
• McGovern D, Owen A. Intensive case management for severe psychotic illness. Lancet 1999; 354(9187):1384.
   PubMed Web of Science ®Google Scholar
• Marshall M, Bond G, Stein LI . PRiSM psychosis study: design limitations, questionable conclusions. Br J Psychiatry 1999;175:501–503.
   PubMed Web of Science ®Google Scholar
• Slade M, Kuipers E, Priebe S. Mental health services research methodology. Int Rev Psychiatry 2002;14:12–18.
   Web of Science ®Google Scholar
• Kazdin AE. Almost clinically significant (p < .10): current measures may only approach clinical significance. Clin Psychol Sci Pract 2001;8:455–462.
   Web of Science ®Google Scholar
• Scheirer MA. A user's guide to program templates: a new tool for evaluating program content. San Francisco, CA: Jossey-Bass, 1996.
   Google Scholar
• Sechrest L, Phillips MA, Redner R, Yeaton W. Some neglected problems in evaluation research: strength and integrity of treatments. Beverly Hills, CA: Sage Publications, 1979.
   Google Scholar
• Yeaton WH, Sechrest L. Critical dimensions in the choice and maintenance of successful treatments: strength, integrity, and effectiveness. J Consult Clin Psychol 1981;49:156–167.
   PubMed Web of Science ®Google Scholar
• Teague GB, Bond GR, Drake RE. Program fidelity in assertive community treatment: development and use of a measure. Am J Orthopsychiatry 1998;68:216–232.
   PubMed Web of Science ®Google Scholar
• McGrew JH, Bond GR, Dietzen L, Salyers M. Measuring the fidelity of implementation of a mental health program model. J Consult Clin Psychol 1994;62:670–678.
   PubMed Web of Science ®Google Scholar
• McGrew JH, Bond GR. Critical ingredients of assertive community treatment: judgments of the experts. J Ment Health Adm 1995;22:113–125.
   PubMedGoogle Scholar
• Bond GR, Williams J, Evans L, Salyers M, Kim H-W, Sharpe H. Psychiatric rehabilitation fidelity toolkit. Cambridge, MA: Evaluation Centre, Human Services Research Institute, 2000.
   Google Scholar
• Teague GB, Drake RE, Ackerson TH. Evaluating use of continuous treatment teams for persons with mental illness and substance abuse. Psychiatr Serv 1995;46:689–695.
   PubMed Web of Science ®Google Scholar
• Mueser KT, Fox L, Bond GR, Salyers M, Yamamoto K, Williams J. Dual-disorder Treatment Fidelity Scale. In: Mueser KT, Noordsy DL, Drake RE, Fox L, eds. Integrated treatment for dual disorder. New York: Guilford Press, 2003:337–354.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Co-occurring disorders: integrated dual disorders treatment. US Dept Health and Human Services, 2003. [cited 5/1/10.] Available from URL: http://mentalhealth.samhsa.gov/cmhs/communitysupport/toolkits/cooccurring
   Google Scholar
• McFarlane WR, Dixon L, Lukens E, Lucksted A. Family psych-oeducation and schizophrenia: a review of the literature. J Marital Fam Ther 2003;29:223–245.
   PubMed Web of Science ®Google Scholar
• Madson MB, Campbell TC. Measures of fidelity in motivational enhancement: a systematic review. J Subst Abuse Treat 2006;31:67–73.
   PubMed Web of Science ®Google Scholar
• Brans EJ, Suter JC, Leverentz-Brady KM. Relations between program and system variables and fidelity to the wraparound process for children and families. Psychiatr Serv 2006;57:1586–1593.
   PubMed Web of Science ®Google Scholar
• Nordness P, Epstein M. Reliability of the Wraparound Observation Form-second version: an instrument designed to assess the fidelity of the wraparound approach. Ment Health Serv Res 2003;5:89–96.
   PubMedGoogle Scholar
• Walker J, Bruns E. Building on practice-based evidence: using expert perspectives to define the wraparound process. Psychiatr Serv 2006;57:1579–1585.
   PubMed Web of Science ®Google Scholar
• Marshall M, Lockwood A, Lewis S, Fiander M. Essential elements of an early intervention service for psychosis: the opinions of expert clinicians. BMC Psychiatry 2004;4:17.
   PubMed Web of Science ®Google Scholar
• McCrone P, Knapp M. Economic evaluation of early intervention services. Br J Psychiatry 2007; 191:S19–S22.
   Web of Science ®Google Scholar
• Nordentoft M, Jeppesen P, Petersen L . Opus project: a randomised, controlled trial of integrated psychiatric treatment in first episode psychosis. Schizophr Res 2003;60:297.
   Web of Science ®Google Scholar
• Kuipers E, Holloway F, Rabe-Hesketh S, Tennakoon L. An RCT of early intervention in psychosis: Croydon Outreach and Assertive Support Team (COAST). Soc Psychiatry Psychiatr Epidemiol 2004;39:358–363.
   PubMed Web of Science ®Google Scholar
• Mihalopoulos C, McGorry PD, Carter RC. Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome? Acta Psychiatr Scand 1999;100:47–55.
   PubMed Web of Science ®Google Scholar
• Salvador-Carulla L, Haro JM, Cabases J, Madoz V, Sacristan JA, Vazquez-Barquero JL. Service utilization and costs of first-onset schizophrenia in two widely differing health service areas in North-East Spain. Acta Psychiatr Scand 1999;100:335–343.
   PubMed Web of Science ®Google Scholar
• Valmaggia L, McCrone P, Knapp M . Economic impact of an early intervention in people at high risk of psychosis. Psychol Med 2009;39:1617–1626.
   PubMed Web of Science ®Google Scholar
• Cullberg J, Mattsson M, Levander S . Treatment costs and clinical outcome for first episode schizophrenia patients: a 3-year follow-up of the Swedish ‘Parachute Project’ and Two Comparison Groups. Acta Psychiatr Scand 2006;114:274–281.
   PubMed Web of Science ®Google Scholar
• Goldberg K, Norman R, Hoch J . Impact of a specialized early intervention service for psychotic disorders on patient characteristics, service use, and hospital costs in a defined catchment area. Can J Psychiatry 2006;51:895–903.
   PubMed Web of Science ®Google Scholar
• Mihalopoulos C, Harris M, Henry L, Harrigan S, McGorry P. Is early intervention in psychosis cost-effective over the long term? Schizophr Bull 2009; 35:909–918.
   PubMed Web of Science ®Google Scholar
• Access Economics. Cost effectiveness of early intervention for psychosis. Melbourne: Access Economics for ORYGEN Research Centre, 2008.
   Google Scholar
• Institute of Medicine of the National Academies. To err is human: building a safer health system. Washington, DC: National Academies Press, 2000.
   Google Scholar
• Institute of Medicine of the National Academies. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: Institute of Medicine, 2002.
   Google Scholar
• Berwick DM. A user's manual for the IOM's ‘quality chasm’ report. Health Aff (Millwood) 2002; 21 (3):80–90.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Quality improvement for mental health, Report No.: 9241545976. Geneva: World Health Organization, 2003.
   Google Scholar
• Institute of Medicine of the National Academies. Improving the quality of health care for mental and substance-use conditions. Washington, DC: National Academies Press, 2006.
   Google Scholar
• Skok A, Swerissen H, Macmillan J. Standards and quality improvement processes in health and community services: a review of the literature. Canberra: Commonwealth Department of Health and Aged Care, 2000.
   Google Scholar
• Lynn J, Baily MA, Bottrell M . The ethics of using quality improvement methods in health care. Ann Intern Med 2007;146:666–673.
   PubMed Web of Science ®Google Scholar
• NHMRC. When does quality assurance in health care require independent ethical review? Canberra: Commonwealth of Australia, 2003.
   Google Scholar
• Leyland AH, Goldstein H. Multilevel modelling of health statistics. Chi Chester: John Wiley and Sons, 2001.
   Google Scholar
• Rogosa D, Brandt D, Zimowski M. A growth curve approach to the measurement of change. Psychol Bull 1982;92:726–748.
   Web of Science ®Google Scholar
• Glover G, Kamis-Gould E. Performance indicators in mental health services. In: Thornicroft G, Strathdee G, eds. Commissioning mental health services. London: HMSO, 1996:265–272.
   Google Scholar
• Arya D, Callay T. Using continuous quality improvement to implement a clinical governance framework in a mental health service. Australas Psychiatry 2005;13:241–246.
   PubMedGoogle Scholar
• Tobin M, Yeo F, Chen L. The beginning of a structural reform: reorganizing the front line of a mental health system. Aust Health Rev 2000;23:64–76.
   PubMedGoogle Scholar
• Berk M, Callaly T, Hyland M. The evolution of clinical audit as a tool for quality improvement. J Eval Clin Pract 2003;9:251–257.
   PubMed Web of Science ®Google Scholar
• McFarland D, Harmann L, Lhotak C, Wieselthier VF. The quest for TQM in a community mental health center: using the Bald-rige criteria as a framework. Jt Comm J Qual Improv 1996;22:37–47.
   PubMedGoogle Scholar
• Hermann RC, Regner JL, Erickson P, Yang DW. Developing a quality management system for behavioral health care: the Cambridge health alliance experience. Harv Rev Psychiatry 2000;8:251–260.
   PubMed Web of Science ®Google Scholar
• Coop CF. Balancing the balanced scorecard for a New Zealand mental health service. Aust Health Rev 2006;30:174.
   PubMedGoogle Scholar
• Tobin MJ, Hickie IB, Yeo FM, Chen L. Discussing the impact of first onset psychosis programs on public sector health services. Australas Psychiatry 1998;6:181–182.
   Google Scholar
• Chong SA, Verma S, Mythily S, Poon LY, McGorry PD. The Early Psychosis Intervention Programme in Singapore: a balanced scorecard approach to quality care. J Ment Health 2008;17:79–91.
   Web of Science ®Google Scholar
• Addington D, McKenzie E, Addington J, Patten S, Smith H, Adair C. Performance measures for early psychosis treatment services. Psychiatr Serv 2005;56:1570–1582.
   PubMed Web of Science ®Google Scholar
• Chong SA, Lee C, Bird L, Verma S. A risk reduction approach for schizophrenia: the early psychosis intervention programme. Ann Acad Med Sing 2004;33:630–635.
   PubMed Web of Science ®Google Scholar
• Catts SV, O'Donnell M, Spencer EA . Early psychosis intervention in routine service environments: implications for case management and service evaluation. In: Kashima H, Falloon IRH, Mizuno M, Asai M, eds. Comprehensive treatment of schizophrenia. Tokyo: Springer-Verlag, 2002.
   Google Scholar
• Yung AR, Harris M. Management of early psychosis in a generic adult mental health service. Aust N Z J Psychiatry 2003;37:429–436.
   PubMed Web of Science ®Google Scholar
• Turner M, Smith-Hamel C, Mulder R. Pathways to care in a New Zealand first-episode of psychosis cohort. Aust N Z J Psychiatry 2006; 40:421–128.
   PubMed Web of Science ®Google Scholar
• Malla A, Schmitz N, Norman R . A multisite Canadian study of outcome of first-episode psychosis treated in publicly funded early intervention services. Can J Psychiatry 2007;52:563–571.
   PubMed Web of Science ®Google Scholar
• O'Kearney R, Garland G, Welch M, Kanowski L, Fitzgerald S. Factors predicting program fidelity and delivery of an early intervention program for first episode psychosis in rural Australia. Aust e-J Adv Ment Health 2004; 3 (2): 1–9.
   Google Scholar
• Field MJ, Lohr KN. Clinical practice guidelines: directions for a new program. Washington, DC: Institute of Medicine, National Academy Press, 1990.
   Google Scholar
• Lehman AF, Steinwachs DM. Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) client survey. Schizophr Bull 1998;24:11–20.
   PubMed Web of Science ®Google Scholar
• Bauer MS. A review of quantitative studies of adherence to mental health clinical practice guidelines. Harv Rev Psychiatry 2002;10:138–153.
   PubMed Web of Science ®Google Scholar
• Gorrell J, Cornish A, Tennant C . Changes in early psychosis service provision: a file audit. Aust N Z J Psychiatry 2004;38:687–693.
   PubMed Web of Science ®Google Scholar
• Hanson LA, Grypma M, Tee KA, MacEwan GW. Evaluation of a community mental health carepath for early psychosis. J Eval Clin Pract 2006;12:112–119.
   PubMed Web of Science ®Google Scholar
• Reilly J, Newton R, Dowling R. Implementation of a first presentation psychosis clinical pathway in an area mental health service: the trials of a continuing quality improvement process. Australas Psychiatry 2007;15:14–18.
   PubMed Web of Science ®Google Scholar
• Mental Health Research Network. A national evaluation of early intervention for psychosis services: DUP, service engagement and outcome. UK National Institute for Health Research, 2005. [cited 5 January 2010.] Available from URL: www.mhrn.info/index/portfolio/Studies/Psychosis/NationalEDEN.html
   Google Scholar
• Fisher H, Theodore K, Power P . Routine evaluation in first episode psychosis services: feasibility and results from the MiData Project. Soc Psychiatry Psychiatr Epidemiol 2008;43:960–967.
   PubMed Web of Science ®Google Scholar
• Catts SV, Carr VC, O'Toole BI . Variance components model predicting outcome in a multi-site, multilevel study of early psychosis treatment. Schizophr Bull 2007; 33:584–585.
   Web of Science ®Google Scholar
• Haro JM, Edgell ET, Novick D . Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study. Acta Psychiatr Scand 2005;111:220–231.
   PubMed Web of Science ®Google Scholar
• Haro JM, Salvador-Carulla L. The SOHO (schizophrenia outpatient health outcome) study: implications for the treatment of schizophrenia. CNS Drugs 2006;20:293–301.
   PubMed Web of Science ®Google Scholar
• Gasquet I, Haro JM, Novick D, Edgell ET, Kennedy L, Lepine JP. Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study. Int Clin Psychopharmacol 2005;20:199–205.
   PubMed Web of Science ®Google Scholar
• McGorry P, Edwards J, Mihalopolous C, Harrigan S, Jackson H. EPPIC: An evolving system of early detection and optimal management. Schizophr Bull 1996:305–326.
   PubMed Web of Science ®Google Scholar
• Cassidy CM, Schmitz N, Norman R, Manchanda R, Malla A. Long-term effects of a community intervention for early identification of first-episode psychosis. Acta Psychiatr Scand 2008; 117:440–148.
   PubMed Web of Science ®Google Scholar
• Joa I, Johannessen JO, Auestad B . The key to reducing duration of untreated first psychosis: information campaigns. Schizophr Bull 2008; 34:466–172.
   PubMed Web of Science ®Google Scholar
• Larsen TK, McGlashan TH, Johannessen JO . Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatment. Am J Psychiatry 2001;158:1917–1919.
   PubMed Web of Science ®Google Scholar
• Rosenbaum B, Valbak K, Harder S . The Danish National Schizophrenia Project: prospective, comparative longitudinal treatment study of first-episode psychosis. Br J Psychiatry 2005;186:394–399.
   PubMed Web of Science ®Google Scholar
• Melle I, Larsen TK, Haahr U . Prevention of negative symptom psychopathologies in first-episode schizophrenia. Arch Gen Psychiatry 2008;65:634–640.
   PubMed Web of Science ®Google Scholar
• Schultze-Lutter F, Picker H, Ruhrmann S, Klosterkotter J. The Cologne early recognition and intervention center for mental crises (FETZ). Evaluation of service use. Med Klin 2008; 103 (2):81–89.
   Google Scholar
• Fossey E, Harvey C, McDermott F, Davidson L. Understanding and evaluating qualitative research. Aust N Z J Psychiatry 2002;36:717–732.
   PubMed Web of Science ®Google Scholar
• Judge AM, Estroff SE, Perkins DO, Penn DL. Recognizing and responding to early psychosis: a qualitative analysis of individual narratives. Psychiatr Serv 2008;59:96–99.
   PubMed Web of Science ®Google Scholar
• Larsen TK, Johannesen JO, McGlashan T, Horneland M, Mardal S, Vaglum P. Can duration of untreated illness be reduced? In: Birchwood M, Fowler D, Jackson C, eds. Early intervention in psychosis. Chichester: John Wiley and Sons, 2000:143–165.
   Google Scholar
• Melle I, Larsen TK, Haahr U . Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry 2004;61:143–150.
   PubMed Web of Science ®Google Scholar
• Johannessen JO, McGlashan TH, Larsen TK . Early detection strategies for untreated first-episode psychosis. Schizophr Res 2001;51:39–46.
   PubMed Web of Science ®Google Scholar
• Larsen TK, Melle I, Auestad B . Early detection of first-episode psychosis: the effect on 1-year outcome. Schizophr Bull 2006;32:758–764.
   PubMed Web of Science ®Google Scholar
• Larsen TK, Melle I, Friis S . One-year effect of changing duration of untreated psychosis in a single catchment area. Br J Psychiatry 2007; 191:S128–S32.
   Web of Science ®Google Scholar
• Maclure M. Taxonomic axes of epidemiologic study designs: a refutationist perspective. J Clin Epidemiol 1991;44:1045–1053.
   PubMed Web of Science ®Google Scholar
• Garety PA, Craig TKJ, Dunn G . Specialised care for early psychosis: symptoms, social functioning and patient satisfaction: randomised controlled trial. Br J Psychiatry 2006;188:37–45.
   PubMed Web of Science ®Google Scholar
• Amminger GP, Schafer MR, Papageorgiou K . Relationship between erythrocyte membrane fatty acids and transition to psychosis in ultra-high risk individuals: basic research findings from a RCT. Schizophr Bull 2009;35:375.
   Web of Science ®Google Scholar
• Berk M, Copolov D, Dean O . N-acetyl cysteine as a glutathione precursor for schizophrenia: a double-blind, randomized, placebo-controlled trial. Biol Psychiatry 2008;64:361–368.
   PubMed Web of Science ®Google Scholar
• Patil ST, Zhang L, Martenyi F . Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med 2007;13:1102–1107.
   PubMed Web of Science ®Google Scholar
• Vonkorff M, Nestadt G, Romanoski A . Prevalence of treated and untreated DSM-III schizophrenia: results of a two-stage community survey. J Nerv Merit Dis 1985;173:577–581.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund PA, Bruce ML . The prevalence and correlates of untreated serious mental illness. Health Serv Res 2001;36:987–1007.
   PubMed Web of Science ®Google Scholar
• Alvarez-Jimenez M, Parker A, Hetrick SE, McGorry PD, Gleeson JF. Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Schiz Bull, DOI: 10.1093/schbul/sbpl29
   Web of Science ®Google Scholar
• Wright A, McGorry PD, Harris MG, Jorm AF, Pennell K. Development and evaluation of a youth mental health community awareness campaign: the Compass Strategy. BMC Public Health 2006;6:215.
   PubMed Web of Science ®Google Scholar
• International Early Psychosis Association Writing Group. International Clinical Practice Guidelines for early psychosis. Br J Psychiatry 2005; 187(Suppl 48): 120–124.
   Google Scholar
• Truswell A. Levels and kinds of evidence for public-health nutrition. Lancet 2001; 357 (9262): 1061–1062.
   PubMed Web of Science ®Google Scholar
• Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet 1995; 345 (8953):840–842.
   PubMed Web of Science ®Google Scholar
• Evans R, Catts SV, O'Toole BI . Is a national framework for implementing early psychosis services necessary? Results of a survey of Australian mental health service directors. Early Interv Psychiatry (in press).
   Web of Science ®Google Scholar
• Hay P, Mulder R, Boyce P. The scientific practitioner in psychiatry for the 21 st century. Australas Psychiatry 2003; 11:442–A45.
   Google Scholar